Business Description
EMvision Medical Devices Ltd
ISIN : AU0000028375
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.85 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | -1.3 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.6 | |||||
3-Year EPS without NRI Growth Rate | 3.7 | |||||
3-Year Book Growth Rate | -8.8 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.47 | |||||
9-Day RSI | 37.56 | |||||
14-Day RSI | 39.76 | |||||
6-1 Month Momentum % | 72.39 | |||||
12-1 Month Momentum % | 64.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.92 | |||||
Quick Ratio | 1.92 | |||||
Cash Ratio | 1.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.9 | |||||
Shareholder Yield % | -1.26 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -51.89 | |||||
ROA % | -28.63 | |||||
ROIC % | -262.73 | |||||
ROC (Joel Greenblatt) % | -418.01 | |||||
ROCE % | -40.82 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 29.45 | |||||
Price-to-Tangible-Book | 30.71 | |||||
EV-to-EBIT | -66.35 | |||||
EV-to-EBITDA | -77.73 | |||||
EV-to-FCF | -49.24 | |||||
Price-to-Net-Current-Asset-Value | 35.83 | |||||
Price-to-Net-Cash | 53.75 | |||||
Earnings Yield (Greenblatt) % | -1.51 | |||||
FCF Yield % | -1.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
EMvision Medical Devices Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.042 | ||
Beta | 2.15 | ||
Volatility % | 48.01 | ||
14-Day RSI | 39.76 | ||
14-Day ATR (A$) | 0.111053 | ||
20-Day SMA (A$) | 2.2745 | ||
12-1 Month Momentum % | 64.63 | ||
52-Week Range (A$) | 1.13 - 2.72 | ||
Shares Outstanding (Mil) | 85.42 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EMvision Medical Devices Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EMvision Medical Devices Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
EMvision Medical Devices Ltd Frequently Asked Questions
What is EMvision Medical Devices Ltd(ASX:EMV)'s stock price today?
When is next earnings date of EMvision Medical Devices Ltd(ASX:EMV)?
Does EMvision Medical Devices Ltd(ASX:EMV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |